CLINICAL_TRIALS
trial_result
· 2015-07-31
Clinical Trial Update: A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM) [Phase 2]
Summary
A Phase 2 study evaluating the performance of a glucose blinding protein-based continuous glucose monitor (GBP CGM) in individuals with Type 1 diabetes mellitus…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Virginia | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2015-07-31